MedTrace Logo

Effect of Bed Height on Chest Compression Quality and Provider Biomechanics During Pediatric CPR Simulation

NCT07329842 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2026-01-09

No results posted yet for this study

Summary

High-quality chest compressions are critical for outcomes after pediatric cardiac arrest, yet rescuer ergonomics and bed height may adversely affect compression quality and fatigue. This randomized crossover simulation study will evaluate how four different bed-height settings influence pediatric CPR quality and rescuer biomechanics. Pediatric emergency medicine residents will perform 2-minute chest-compression-only CPR on a pediatric manikin placed on a hospital bed under four bed-height conditions in randomized order across separate sessions. CPR quality metrics from the manikin's feedback system, rescuer fatigue, physiologic responses, and arm angle over time will be compared to identify an ergonomically optimal bed-height approach.

Conditions

  • Pediatric Cardiac Arrest (Simulated)
  • Cardiopulmonary Resuscitation, Simulation Training
  • In-Hospital Cardiac Arrest
  • Rescuer Fatigue During CPR
  • CPR Quality Assessment
  • Bed Height in CPR

Interventions

OTHER

Fixed Standard Bed Height (58 cm)

Hospital bed height is set to a fixed standard height of 58 cm for the CPR session.

OTHER

Anthropometry-Based Bed Height (Patella Midpoint)

Hospital bed height is adjusted to the participant's patella midpoint reference before the CPR session.

OTHER

Anthropometry-Based Bed Height (Lower One-Third Patella-ASIS)

Hospital bed height is adjusted to the lower one-third point of the distance between the patella and ASIS before the CPR session.

OTHER

Self-Selected Bed Height

Participant selects the bed height they perceive as optimal/comfortable prior to the CPR session.

Sponsors & Collaborators

  • Akdeniz University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-28
Primary Completion
2026-02-01
Completion
2026-04-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07329842 on ClinicalTrials.gov